Adaptimmune Therapeutics PLC (ADAP)
0.5788
-0.01
(-1.56%)
USD |
NASDAQ |
Dec 24, 16:00
0.60
+0.02
(+3.66%)
After-Hours: 06:07
Adaptimmune Therapeutics Market Cap: 148.11M for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals PLC | 2.491M |
| NuCana PLC | 4.730M |
| TC BioPharm (Holdings) PLC | 5.176M |
| Verona Pharma PLC | 3.686B |
| Autolus Therapeutics PLC | 598.77M |
Market Cap Related Metrics
| PS Ratio | 0.8142 |
| Price to Book Value | 1.852 |
| Price | 0.5788 |
| Earnings Yield | -31.10% |